Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Karima Amaador"'
Autor:
Karima Amaador, Pythia T. Nieuwkerk, Monique C. Minnema, Marie José Kersten, Josephine M. I. Vos
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3376-3386 (2023)
Abstract Introduction Treatment options for Waldenström's Macroglobulinemia (WM) have expanded rapidly in the last decades. However, there is no consensus on a preferred treatment. Therefore, patient preferences become increasingly important in maki
Externí odkaz:
https://doaj.org/article/1f3f15c7d1d242fcb3c1a501b8d78c1e
Autor:
Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 704-717 (2022)
Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international consensus on a preferred first line treatment approa
Externí odkaz:
https://doaj.org/article/82f4cd8b98654e7fb1dcdbb12f8fdac0
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e746 (2022)
Waldenström’s macroglobulinemia (WM), a rare low-grade B-cell non-Hodgkin lymphoma (NHL), has a distinct clinical presentation and different treatment-related side effects compared with other NHL. Currently, a wide variety of therapeutic agents ar
Externí odkaz:
https://doaj.org/article/2325e99ea1a24e968780e167e4e3f0a0
Publikováno v:
HemaSphere, Vol 5, Iss 2, p e527 (2021)
Externí odkaz:
https://doaj.org/article/72d3e8a8c18b488fb13b7be4c6e17300
Autor:
Karima Amaador, Pythia T. Nieuwkerk, Monique C. Minnema, Marie José Kersten, Josephine M. I. Vos
Publikováno v:
Cancer medicine. John Wiley and Sons Ltd
Amaador, K, Nieuwkerk, P T, Minnema, M C, Kersten, M J & Vos, J M I 2022, ' Patient preferences regarding treatment options for Waldenström's macroglobulinemia : A discrete choice experiment ', Cancer Medicine . https://doi.org/10.1002/cam4.5080
Cancer Medicine. John Wiley and Sons Ltd
Amaador, K, Nieuwkerk, P T, Minnema, M C, Kersten, M J & Vos, J M I 2022, ' Patient preferences regarding treatment options for Waldenström's macroglobulinemia : A discrete choice experiment ', Cancer Medicine . https://doi.org/10.1002/cam4.5080
Cancer Medicine. John Wiley and Sons Ltd
Introduction: Treatment options for Waldenström's Macroglobulinemia (WM) have expanded rapidly in the last decades. However, there is no consensus on a preferred treatment. Therefore, patient preferences become increasingly important in making indiv
Autor:
Fritz Offner, Karima Amaador, Kazem Nasserinejad, Dries Deeren, Efstathios Kastritis, Steven T. Pals, Willem Kraan, Jeanette K. Doorduijn, Roberto D Liu, Monique C. Minnema, Marcel Kap, Marie José Kersten, Lara H Böhmer, Lidwine W. Tick, Meletios A. Dimopoulos, Josephine M.I. Vos, Martine E D Chamuleau, Maria Gavriatopoulou
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(1), 40-51. American Society of Clinical Oncology
Kersten, M J, Amaador, K, Minnema, M C, Vos, J M I, Nasserinejad, K, Kap, M, Kastritis, E, Gavriatopoulou, M, Kraan, W, Chamuleau, M E D, Deeren, D, Tick, L W, Doorduijn, J K, Offner, F, Böhmer, L H, Liu, R D, Pals, S T & Dimopoulos, M A 2022, ' Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 1, pp. 40-51 . https://doi.org/10.1200/JCO.21.00105
Journal of clinical oncology, 40(1), 40-51. American Society of Clinical Oncology
PURPOSE Proteasome inhibitors are effective in Waldenström's macroglobulinemia (WM) but require parenteral administration and are associated with polyneuropathy. We investigated efficacy and toxicity of the less neurotoxic oral proteasome inhibitor
Autor:
Karima Amaador, Anne Martens, Renate de Boer, Joanne Rietveld, Mirjam Heemskerk, Caroline E. Rutten, Eric Eldering, Marie-José Kersten, Arnon P. Kater, Josephine Vos, Sanne Tonino
Publikováno v:
Leukemia and Lymphoma, 63(6), 1469-1473. Informa Healthcare
Amaador, K, Martens, A, de Boer, R, Rietveld, J, Heemskerk, M, Rutten, C E, Eldering, E, Kersten, M-J, Kater, A P, Vos, J & Tonino, S 2022, ' T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia ', Leukemia and Lymphoma, vol. 63, no. 6, pp. 1469-1473 . https://doi.org/10.1080/10428194.2022.2030478
Leukemia & lymphoma, 63(6), 1469-1473. Informa Healthcare
Amaador, K, Martens, A, de Boer, R, Rietveld, J, Heemskerk, M, Rutten, C E, Eldering, E, Kersten, M-J, Kater, A P, Vos, J & Tonino, S 2022, ' T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia ', Leukemia and Lymphoma, vol. 63, no. 6, pp. 1469-1473 . https://doi.org/10.1080/10428194.2022.2030478
Leukemia & lymphoma, 63(6), 1469-1473. Informa Healthcare
Autor:
Karima, Amaador, Luuk, Wieske, Marleen J A, Koel-Simmelink, A, Kamp, Ilse, Jongerius, Koen, de Heer, Charlotte E, Teunissen, Monique C, Minnema, Nicolette C, Notermans, Filip, Eftimov, Marie José, Kersten, Josephine M I, Vos
Publikováno v:
Journal of neurology. 269(7)
In anti-myelin-associated glycoprotein IgM paraprotein-related peripheral neuropathy (anti-MAG PN), there is a lack of reliable biomarkers to select patients eligible for therapy and for evaluating treatment effects, both in routine practice and in c
Publikováno v:
Amaador, K, Kersten, M J, Minnema, M C & Vos, J M I 2022, ' Treatment of relapsed and refractory Waldenstrom Macroglobulinemia ', Leukemia and Lymphoma . https://doi.org/10.1080/10428194.2022.2131423
Waldenström’s Macroglobulinemia (WM) is a rare type of indolent non-Hodgkin lymphoma (NHL) that remains incurable. Several effective agents such as monoclonal antibodies (in combination with chemotherapy), Bruton’s tyrosine kinase inhibitors, pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe0ad02c728a9581b857b37b86a2a01
https://research.vumc.nl/en/publications/027208d5-8429-405a-af90-923e02144ab1
https://research.vumc.nl/en/publications/027208d5-8429-405a-af90-923e02144ab1
Autor:
R de Boer, Arnon P. Kater, Sanne H. Tonino, Karima Amaador, Eric Eldering, Marie-Jose Kersten, Josephine M.I. Vos, Anne W. J. Martens, J. M Rietveld
Publikováno v:
Hematological Oncology. 39